Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bernd Kost

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Reproductive Toxicology (Elmsford, N.Y.)|December 3, 2014
Analysis of endoplasmic reticulum stress in placentas of HIV-infected women treated with protease inhibitorsAnsgar Brüning, Tanja Kimmich, German J Brem, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|March 28, 2015
Expression of Thyroid Hormone Receptors in Villous Trophoblasts and Decidual Tissue at Protein and mRNA Levels Is Downregulated in Spontaneous and Recurrent MiscarriagesBrigitte Ziegelmüller, Aurelia Vattai, Bernd Kost, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|October 19, 2015
The expression of thyroid hormone receptors (THR) is regulated by the progesterone receptor system in first trimester placental tissue and in BeWo cells in vitroAurelia Vattai, Brigitte Ziegelmüller, Bernd Kost, et al.
Journal of Cancer Research and Clinical Oncology|September 20, 2017
The G protein-coupled estrogen receptor (GPER/GPR30) may serve as a prognostic marker in early-stage cervical cancerKlaus Friese, Bernd Kost, Aurelia Vattai, et al.
Journal of Medical Case Reports|July 8, 2023
Clear cell endometrial carcinoma with high microsatellite instability in a complicated pregnancy: a case reportFabian Weiss, Till Kaltofen, Veronika Kanitz, et al.
Anticancer Research|June 9, 2016
Immunohistochemical Evaluation of the Role of p53 Mutation in Cervical Cancer: Ser-20 p53-Mutant Correlates with Better PrognosisChristoph P Freier, Annika Stiasny, Christina Kuhn, et al.
Journal of Cancer Research and Clinical Oncology|August 1, 2018
TA-MUC1 as detected by the fully humanized, therapeutic antibody Gatipotzumab predicts poor prognosis in cervical cancerSabine Heublein, Klaus Friese, Bernd Kost, et al.
International Journal of Molecular Sciences|February 11, 2023
Expression of Progesterone Receptor A as an Independent Negative Prognosticator for Cervical CancerFabian Garrido, Carl Mathis Wild, Udo Jeschke, et al.
Oncology|March 4, 2016
Comparison of HER2 Expression in Primary Tumor and Disseminated Tumor Cells in the Bone Marrow of Breast Cancer PatientsBrigitte Rack, Ewa Zombirt, Elisabeth Trapp, et al.
Oncotarget|December 30, 2017
Investigation of RIP140 and LCoR as independent markers for poor prognosis in cervical cancerAurelia Vattai, Vincent Cavailles, Sophie Sixou, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Reproductive Toxicology (Elmsford, N.Y.)|December 3, 2014
Analysis of endoplasmic reticulum stress in placentas of HIV-infected women treated with protease inhibitorsAnsgar Brüning, Tanja Kimmich, German J Brem, et al.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|March 28, 2015
Expression of Thyroid Hormone Receptors in Villous Trophoblasts and Decidual Tissue at Protein and mRNA Levels Is Downregulated in Spontaneous and Recurrent MiscarriagesBrigitte Ziegelmüller, Aurelia Vattai, Bernd Kost, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|October 19, 2015
The expression of thyroid hormone receptors (THR) is regulated by the progesterone receptor system in first trimester placental tissue and in BeWo cells in vitroAurelia Vattai, Brigitte Ziegelmüller, Bernd Kost, et al.
Journal of Cancer Research and Clinical Oncology|September 20, 2017
The G protein-coupled estrogen receptor (GPER/GPR30) may serve as a prognostic marker in early-stage cervical cancerKlaus Friese, Bernd Kost, Aurelia Vattai, et al.
Journal of Medical Case Reports|July 8, 2023
Clear cell endometrial carcinoma with high microsatellite instability in a complicated pregnancy: a case reportFabian Weiss, Till Kaltofen, Veronika Kanitz, et al.
Anticancer Research|June 9, 2016
Immunohistochemical Evaluation of the Role of p53 Mutation in Cervical Cancer: Ser-20 p53-Mutant Correlates with Better PrognosisChristoph P Freier, Annika Stiasny, Christina Kuhn, et al.
Journal of Cancer Research and Clinical Oncology|August 1, 2018
TA-MUC1 as detected by the fully humanized, therapeutic antibody Gatipotzumab predicts poor prognosis in cervical cancerSabine Heublein, Klaus Friese, Bernd Kost, et al.
International Journal of Molecular Sciences|February 11, 2023
Expression of Progesterone Receptor A as an Independent Negative Prognosticator for Cervical CancerFabian Garrido, Carl Mathis Wild, Udo Jeschke, et al.
Oncology|March 4, 2016
Comparison of HER2 Expression in Primary Tumor and Disseminated Tumor Cells in the Bone Marrow of Breast Cancer PatientsBrigitte Rack, Ewa Zombirt, Elisabeth Trapp, et al.
Oncotarget|December 30, 2017
Investigation of RIP140 and LCoR as independent markers for poor prognosis in cervical cancerAurelia Vattai, Vincent Cavailles, Sophie Sixou, et al.
Pageof 3